BRIEF: InnoCare, KeyMed in antibody licensing agree with Prolium
Biopharmaceutical company InnoCare Pharma Ltd. (9969.HK; 688428.SH) announcedon Monday that it, along with KeyMed (2162.HK) and their joint venture have signed a licensing deal for one of their products with…
Fast-growing Duoning Biotech seeks winning formula for pricey IPO
The provider of bioprocessing services for the drugs sector has been expanding rapidly via aggressive M&A, backed by big-name investors Key Takeaways: WuXi Biologics is Duoning Biotechnology’s biggest client and…
Recent Articles
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK -
Inmagene Bio charts backdoor to U.S. listing with offshore acquisition
IKNA.US
-
BRIEF: InnoCare revenue jumps 37% in 2024 on strong lymphoma drug sales
9969.HK 688428.SHG
-
Drinda New Energy powers up IPO for overseas expansion
002865.SHE
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
CARsgen seeks cell therapy breakthrough but stays in the red for now
2171.HK
- Waiting for new industry dawn, SolarSpace turns to IPO for warmth
